Routine insider filing with no trading activity or material change. Monitor future Form 4 filings for any open-market purchases or sales by this officer.
How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+5- T+0 · Nov 9 $476.70entry
- T+1 · 7d ago −0.25%α +0.12% · $475.52
- T+5 · 15h ago −4.88%α −3.19% · $453.42
- T+20 · in 21d Pending
- T+60 · in 3mo Pending
Price Chart
How similar events traded
Executive Summary
Steven Conly filed a Form 3 initial statement of beneficial ownership with Waters Corp, disclosing 6,030 shares of common stock (including restricted stock units) and multiple tranches of stock appreciation rights and stock options. The filing is a routine Section 16 reporting requirement for a new officer (SVP, Waters Biosciences) and contains no material financial or operational information.
Key Facts
- Steven Conly appointed SVP, Waters Biosciences
- Reports 6,030 shares of common stock (including 339 shares, 117 RSUs under 2020 plan, 5,574 RSUs under 2026 plan)
- Holds stock appreciation rights at exercise prices from $411.85 to $464.50, expiring 2027-2034
- Holds a stock option for 574 shares at $319.44, expiring 2036
- RSUs vest in installments through November 2028
- Power of Attorney filed for Section 16 reporting
Financial Impact
No financial impact; initial beneficial ownership disclosure for a new officer
Risk Factors
- No material risks identified from this filing
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 4 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 3 Filing (Primary) | 0001000697-26-000146 |
| Document: 0001000697-26-000146-index-headers.html | 0001000697-26-000146 |
| Document: 0001000697-26-000146-index.html | 0001000697-26-000146 |
| Document: 0001000697-26-000146.txt | 0001000697-26-000146 |
Track record
7 reports on WAT
4 of 4 bullish or bearish reports moved the stock their way by T+5. Best: +18.30% at T+60 after the Aug 4, 2026 report. 4 of 4 went positive at some point.
Filters
- Nov 6, 202610d ago 3 Neutral 2/10 Viewing Entry $476.70 to $453.42 Now $453.42 −4.88% ▼ −4.88% −3.19% vs SPY
- Nov 3, 202613d ago 8-K Bullish 6/10 Entry $459.90 to $475.52 Now $453.42 −1.41% ▲ +3.40% +3.98% vs SPY
- Nov 3, 202613d ago Press Release Bullish 6/10 Entry $459.90 to $475.52 Now $453.42 −1.41% ▲ +3.40% +3.98% vs SPY
- Aug 21, 202612w ago 8-K Neutral 3/10 Entry $410.70 to $414.69 Now $453.42 +10.40% ▲ +0.97% +0.50% vs SPY
- Aug 4, 202614w ago Press Release Bullish 7/10 Entry $396.08 to $415.00 Now $453.42 +14.48% ▲ +4.78% +4.88% vs SPY
- Jun 25, 202620w ago Institutional Cluster Neutral 4/10 Entry $376.89 to $378.13 Now $453.42 +20.31% ▲ +0.33% −1.23% vs SPY
- May 5, 202627w ago 8-K Bullish 8/10 Entry $342.75 to $352.21 Now $453.42 +32.29% ▲ +2.76% +0.78% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers